Migraine Research Frontiers: Genetics, CGRP, Neuromodulation, and Personalized Medicine
Migraine research has advanced across multiple domains:
- Genetics/GWAS: >100 loci identified; shared with vascular, neuronal pathways.
- Neuroimaging: fMRI, PET reveal hypothalamic, brainstem, cortical activation during attacks; structural changes in chronic migraine.
- Trigeminovascular system: Central role of CGRP, PACAP, glutamate.
- CGRP‑targeted therapies: Monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) and gepants (ubrogepant, rimegepant, atogepant) – transformative for acute and preventive treatment.
- Serotonin (5‑HT₁F) agonists: Lasmiditan (acute, no vasoconstriction).
- Neuromodulation: Non‑invasive (eTNS, nVNS, sTMS) and invasive (SPG stimulation).
- Comorbidities & triggers: Sleep, stress, hormones, diet, obesity – bidirectional links.
- Sex differences: Estrogen modulation explains female predominance.
- Biomarkers: CGRP, calcitonin, neurofilament light, imaging signatures for prediction/response.
- Long‑term outcomes: Medication‑overuse headache, chronic migraine progression, cardiovascular risk.
Precision medicine—matching therapy to phenotype/genotype—is the emerging paradigm.
Migraine - Related Articles
- Understanding and Managing Migraine Pain: Causes, Symptoms & Treatment
- Triptans for Migraines: A Comprehensive Guide
- Chronic Daily Migraines: Symptoms, Diagnosis & Management | [Your Brand/Website Name]
- Methadone and Fioricet (Butalbital) Interaction: Respiratory Depression Risk
- Hemiplegic Migraine Treatments: Understanding Options & Management
- Blue Light Therapy for Migraines: Benefits & Risks
- Migraine Relief: Understanding OTC Remedies & Causes
